These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33738859)

  • 41. Lower
    Tjörnstrand A; Casar-Borota O; Heurling K; Schöll M; Gjertsson P; Himmelman J; Itsenko O; Ragnarsson O; Filipsson Nyström H
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):222-231. PubMed ID: 31868239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience.
    Brzana J; Yedinak CG; Gultekin SH; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):490-8. PubMed ID: 23184260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
    Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
    J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies.
    Chinezu L; Vasiljevic A; Jouanneau E; François P; Borda A; Trouillas J; Raverot G
    Hum Pathol; 2014 Jan; 45(1):71-7. PubMed ID: 24182563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
    Yamato A; Nagano H; Gao Y; Matsuda T; Hashimoto N; Nakayama A; Yamagata K; Yokoyama M; Gong Y; Shi X; Zhahara SN; Kono T; Taki Y; Furuki N; Nishimura M; Horiguchi K; Iwadate Y; Fukuyo M; Rahmutulla B; Kaneda A; Hasegawa Y; Kawashima Y; Ohara O; Ishikawa T; Kawakami E; Nakamura Y; Inoshita N; Yamada S; Fukuhara N; Nishioka H; Tanaka T
    Commun Biol; 2022 Nov; 5(1):1304. PubMed ID: 36435867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours.
    Øystese KAB; Casar-Borota O; Berg-Johnsen J; Berg JP; Bollerslev J
    Endocrine; 2022 Jun; 77(1):151-159. PubMed ID: 35674926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.
    Mazarakis N; Kontogeorgos G; Kovacs K; Horvath E; Borboli N; Piaditis G
    Pituitary; 2001 Sep; 4(4):215-21. PubMed ID: 12501971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment.
    Trouillas J; Vasiljevic A; Lapoirie M; Chinezu L; Jouanneau E; Raverot G
    Minerva Endocrinol; 2019 Jun; 44(2):129-136. PubMed ID: 30531694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current pathological classification of pituitary adenomas.
    Saeger W
    Acta Neurochir Suppl; 1996; 65():1-3. PubMed ID: 8738481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
    Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinicopathological Analysis of Densely and Sparsely Granulated Somatotroph Tumors of Pituitary.
    Wang L; He X; Lu L; Chen L; Peng C; Shao C; Ge R
    World Neurosurg; 2024 May; 185():e713-e720. PubMed ID: 38408701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.
    Swanson AA; Erickson D; Donegan DM; Jenkins SM; Van Gompel JJ; Atkinson JLD; Erickson BJ; Giannini C
    Pituitary; 2021 Apr; 24(2):192-206. PubMed ID: 33074402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study.
    Asa SL; Felix I; Kovacs K; Ramyar L
    Endocr Pathol; 1990 Dec; 1(4):228-235. PubMed ID: 32357614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.